MapLight Therapeutics, Inc. · Brief

Next report

32 days

Dec 3 · before openest.Q3 FY26

Expected move

No implied move.

5 reportsHistory

—≥ implied

Q3 FY25—▲+8.39%—

Jan 9 '26—▲+4.83%—

Q1 FY26—▲+6.01%—

May 14 '26—▼−1.91%—

Q2 FY26±16.4%▲+1.47%×0.09

quarterimplied−20%0+20%realized×

Q2 FY26±16.4%▲+1.47%×0.09

May '26—▼−1.91%—

Q1 FY26—▲+6.01%—

Jan '26—▲+4.83%—

Q3 FY25—▲+8.39%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Dec 3 report · est.

Bull2 of 4

3disclosed supplier and customer ties in the company's SEC filingsSEC filings

4tracked funds holding MPLTN-PORT · Aug 31 '26

Bear2

0.17%of State Street SPDR S&P Biotech ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26

9 of 22of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

MPLT report session

No linked exposure.

No changes.

privateThesis 0 · Decisions 0 · Observations 0

No thesis.